$83.44
0.60[0.72%]
At close: May 17
$83.44
0[0.00%]
After Hours: 4:07PM EDT
Bio-Techne: Insider buying and selling updated today.
May 16, 2024 | John L Higgins | DIRECTOR | 0 | $53.40 | -$243.58K | SELL-OPTIONS | 0.00% | 36.608K | May 14 | View |
Mar 11, 2024 | Roeland Nusse | DIRECTOR | -10.4K | $76.98 | -$800.63K | SELL | -19.44% | 43.097K | Mar 07 | View |
Sep 01, 2023 | Roeland Nusse | DIRECTOR | 23.061K | $51.36 | -$1.16K | SELL-OPTIONS | 80.04% | 51.872K | Aug 30 | View |
Jul 25, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -80K | $88.36 | -$7.07M | SELL | -5.97% | 1.259166M | Jul 21 | View |
Jun 09, 2023 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | -322 | $83.00 | -$26.73K | SELL | -0.03% | 1.113217M | Jun 07 | View |
Dec 09, 2022 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $56.69 | -$419.50K | SELL-OPTIONS | 0.00% | 31.412K | Dec 07 - Dec 08 | View |
Aug 12, 2022 | JOHN HIGGINS | DIRECTOR | 896 | $222.85 | -$721.06K | SELL-OPTIONS | 19.45% | 5.502K | Aug 10 - Aug 11 | View |
Jun 09, 2022 | JOHN HIGGINS | — | 0 | $215.94 | -$476.92K | SELL-OPTIONS | 0.00% | 4.606K | Jun 07 - Jun 08 | View |
Jun 09, 2022 | Charles Kummeth | CHIEF EXECUTIVE OFFICER | 0 | $236.75 | -$1.31M | SELL-OPTIONS | 0.00% | 198.438K | Jun 07 | View |
May 11, 2022 | Robert V Baumgartner | — | 300 | $352.55 | $105.77K | BUY | 3.06% | 10.106K | May 10 | View |
Nov 23, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | 0 | $328.08 | -$177.30K | SELL-OPTIONS | 0.00% | 0 | Nov 19 | View |
Nov 16, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | 799 | $314.53 | -$10.19M | SELL-OPTIONS | 60.62% | 2.117K | Nov 12 - Nov 16 | View |
Nov 03, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $325.77 | -$3.62M | SELL-OPTIONS | 0.00% | 10.755K | Nov 01 - Nov 02 | View |
Nov 01, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | -100 | $325.14 | -$317.44K | SELL | -0.92% | 10.755K | Oct 28 - Oct 29 | View |
Sep 24, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -822 | $529.04 | -$434.87K | SELL | -100.00% | 0 | Sep 22 | View |
Sep 09, 2021 | Randolph C Steer | DIRECTOR | 0 | $299.78 | -$3.36M | SELL-OPTIONS | 0.00% | 5.112K | Sep 07 | View |
Sep 07, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $306.90 | -$4.01M | SELL-OPTIONS | 0.00% | 10.855K | Sep 02 | View |
Sep 07, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $317.49 | -$2.64M | SELL-OPTIONS | 0.00% | 7.62K | Sep 02 | View |
Sep 02, 2021 | N. David Eansor pursuant to Power of Attorney previously filed. | PRESIDENT-PROTEIN SCIENCES | -1.538K | $503.07 | -$773.73K | SELL | -53.85% | 1.318K | Aug 31 | View |
Sep 02, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 0 | $315.36 | -$1.90M | SELL-OPTIONS | 0.00% | 7.62K | Aug 31 | View |
Aug 25, 2021 | Roeland Nusse | DIRECTOR | 0 | $275.93 | -$1.64M | SELL-OPTIONS | 0.00% | 6.765K | Aug 23 | View |
Aug 25, 2021 | Robert V Baumgartner | DIRECTOR | 0 | $286.47 | -$1.59M | SELL-OPTIONS | 0.00% | 9.612K | Aug 23 | View |
Aug 23, 2021 | Brenda S Furlow | SVP - GENERAL COUNSEL | 799 | $291.97 | -$1.20M | SELL-OPTIONS | 11.71% | 7.62K | Aug 19 | View |
Aug 10, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 1.718K | $292.95 | -$4.53M | SELL-OPTIONS | 18.80% | 10.855K | Aug 08 - Aug 09 | View |
Jul 14, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $281.63 | -$3.50M | SELL-OPTIONS | 0.00% | 9.137K | Jul 12 | View |
Jun 21, 2021 | Charles R Kummeth | CHIEF EXECUTIVE OFFICER | -12.498K | $449.67 | -$5.62M | SELL | -7.48% | 154.506K | Jun 17 - Jun 18 | View |
Jun 16, 2021 | Charles R Kummeth | CHIEF EXECUTIVE OFFICER | -7.481K | $449.15 | -$3.36M | SELL | -4.29% | 167.004K | Jun 14 | View |
Jun 11, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -811 | $433.00 | -$351.16K | SELL | -100.00% | 0 | Jun 09 | View |
Jun 09, 2021 | James Hippel | CHIEF FINANCIAL OFFICER | 0 | $264.26 | -$3.14M | SELL-OPTIONS | 0.00% | 9.137K | Jun 07 | View |
May 27, 2021 | Kim Kelderman | PRES. DIAGNOSTICS & GENOM | -845 | $424.00 | -$358.28K | SELL | -51.03% | 811 | May 25 | View |
Browse insider trades on all stocks.